Polar Capital’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-225,000
Closed -$17.3M 309
2020
Q2
$17.3M Buy
+225,000
New +$17.2M 0.15% 138
2019
Q4
Sell
-285,000
Closed -$18.1M 294
2019
Q3
$18.1M Sell
285,000
-15,000
-5% -$981K 0.16% 154
2019
Q2
$20.3M Buy
+300,000
New +$19.7M 0.18% 148
2019
Q1
Sell
-225,000
Closed -$14.1M 275
2018
Q4
$14.1M Buy
225,000
+24,896
+12% +$1.74M 0.15% 152
2018
Q3
$15.4M Buy
200,104
+9,104
+5% +$688K 0.13% 161
2018
Q2
$13.5K Buy
191,000
+41,000
+27% +$2.9M 0.08% 176
2018
Q1
$11.3M Buy
+150,000
New +$11.9M 0.11% 177
2017
Q3
Sell
-85,000
Closed -$6.02M 244
2017
Q2
$6.02M Sell
85,000
-5,000
-6% -$333K 0.08% 179
2017
Q1
$6.11M Buy
90,000
+32,000
+55% +$2.25M 0.09% 169
2016
Q4
$4.15M Sell
58,000
-10,000
-15% -$743K 0.07% 203
2016
Q3
$5.38M Buy
68,000
+22,591
+50% +$1.84M 0.09% 175
2016
Q2
$3.79M Sell
45,409
-429,643
-90% -$38.1M 0.07% 193
2016
Q1
$43.6M Buy
475,052
+410,332
+634% +$37M 0.82% 38
2015
Q4
$6.55M Buy
64,720
+22,416
+53% +$2.33M 0.12% 157
2015
Q3
$4.15M Buy
42,304
+7,454
+21% +$828K 0.08% 189
2015
Q2
$4.08M Buy
34,850
+14,468
+71% +$1.58M 0.08% 191
2015
Q1
$2M Buy
20,382
+9,222
+83% +$936K 0.04% 218
2014
Q4
$1.05M Buy
11,160
+3,565
+47% +$369K 0.02% 233
2014
Q3
$808K Sell
7,595
-819
-10% -$80.2K 0.02% 240
2014
Q2
$698K Sell
8,414
-424,124
-98% -$33M 0.01% 247
2014
Q1
$30.6M Buy
432,538
+131,816
+44% +$10.3M 0.7% 37
2013
Q4
$22.6M Buy
300,722
+722
+0.2% +$50.3K 0.54% 56
2013
Q3
$18.9K Sell
300,000
-40,000
-12% -$2.39M 0.5% 55
2013
Q2
$17.4M Buy
+340,000
New +$17.7M 0.61% 49

Other funds holding GILD

Polar Capital's GILD Position: Q3 2020 in Review

Polar Capital sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 225,000 shares — an estimated $17.3M sold.

Polar Capital first reported a position in GILD in Q2 2013 and held it in 24 quarters. The position peaked at $43.6M in Q1 2016. 1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

  • Polar Capital reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
  • Polar Capital sold 225,000 Gilead Sciences shares in Q3 2020, an estimated $17.3M.
  • Polar Capital first reported a position in Gilead Sciences in Q2 2013 and held it in 24 quarters.
  • Polar Capital's Gilead Sciences position peaked at $43.6M in Q1 2016.
  • 1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on Polar Capital's 13F filing for Q3 2020, filed 16 Nov 2020.